DFDS: ACQUISITION OF HSF LOGISTICS GROUP APPROVED
September 06, 2021 12:58 ET
|
DFDS A/S
COMPANY ANNOUNCEMENT NO. 27/2021 The EU Commission has today approved DFDS’ acquisition of the HSF Logistics Group announced on 26 January 2021. The closing of the transaction is expected to be...
Pure Extracts Ships Initial Vape and Edible Order to Private Saskatchewan Cannabis Distributor
August 26, 2021 08:45 ET
|
Pure Extracts Technologies Corp.
VANCOUVER, British Columbia, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction...
Investar Holding Corporation Announces Acquisition Approvals
March 17, 2021 07:00 ET
|
Investar Holding Corporation
BATON ROUGE, La., March 17, 2021 (GLOBE NEWSWIRE) -- Investar Holding Corporation (the “Company”) (Nasdaq:ISTR), the holding company of Investar Bank, National Association (the “Bank”), today...
Misonix Receives Health Canada Approval for neXus
March 04, 2021 09:25 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer
December 16, 2020 16:30 ET
|
MacroGenics, Inc.
MARGENZA (margetuximab-cmkb) is the first HER2-targeted therapy to have improved progression-free survival (PFS) versus Herceptin® (trastuzumab), both combined with chemotherapy, in a head-to-head...
Osisko Gold Royalties Ltd and Barolo Ventures Corp. Provide Transaction Updates on Previously-announced Spin-out Transaction
November 23, 2020 17:00 ET
|
Osisko Gold Royalties Ltd.
Filing of Filing Statement – TSX-V Conditional Approval – Barolo Shareholder Approval MONTRÉAL, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd ("Osisko Royalties") (OR: TSX &...
Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection
August 10, 2020 06:30 ET
|
Trevena Inc.
OLINVYK is a new chemical entity approved in adults for the management of acute pain severe enough to require an IV opioid analgesic OLINVYK product availability expected in fourth quarter of 2020 ...
Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19
July 13, 2020 03:30 ET
|
Equillium
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon Biocon has received emergency use approval from Drugs Controller General of...
dynaCERT Graduates in the USA to the OTCQX
June 09, 2020 05:00 ET
|
dynaCERT Inc.
TORONTO, June 09, 2020 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQX: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce the Company has qualified to trade on the...
ALBIOMA : Assemblée Générale des actionnaires du 29 mai 2020 - Approbation de l’ensemble des résolutions - Renouvellement du mandat de Directeur Général de Frédéric Moyne
May 29, 2020 12:00 ET
|
ALBIOMA
Communiqué de presse Paris La Défense, le 29 mai 2020 Assemblée Générale des actionnaires du 29 mai 2020 Approbation de l’ensemble des résolutions Renouvellement du mandat de Directeur Général de...